Indikof LS Syrup Sugar Free is a combination pharmaceutical formulation containing Ambroxol (30mg/5ml), Levosalbutamol (1mg/5ml), and Guaifenesin (50mg/5ml), designed for the symptomatic management of respiratory conditions characterized by excessive mucus production, bronchospasm, and cough. Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus from the respiratory tract, thereby improving airway patency. Levosalbutamol, a selective β2-adrenergic receptor agonist, provides bronchodilation by relaxing bronchial smooth muscles, which helps alleviate bronchospasm and improves airflow in obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD). Guaifenesin serves as an expectorant, enhancing the hydration of respiratory tract secretions, which aids in loosening and thinning mucus, promoting effective expectoration. The sugar-free formulation makes Indikof LS Syrup suitable for diabetic patients or those requiring sugar-restricted diets. This combination offers a comprehensive approach to managing cough and respiratory congestion by addressing multiple pathophysiological mechanisms. Indikof LS Syrup should be used under medical supervision, with dosage adjustments based on patient age, severity of symptoms, and clinical response, while monitoring for potential side effects such as tachycardia, gastrointestinal disturbances, or hypersensitivity reactions.